Summary.
In the central nervous system, transcription factor AP-2 family is one of the critical regulatory factors for neural gene expression and neuronal development. Several genes in the monoaminergic systems display AP-2 binding sites in regulatory regions. In addition, brainstem levels of transcription factor AP-2α and AP-2β are positively correlated to monoamine measures in rat forebrain, suggesting a regulatory role of AP-2 also in the adult brain. Great changes in psychiatric phenotypes due to genetic factors are seldom the result of a single gene polymorphism. Recently, identification of combinations of candidate genes that are all linked to one disease or psychiatric phenotype has been discussed. The expression of these candidate genes might be regulated by the same transcription factors, e.g. AP-2. Recent data on transcription factor AP-2 family in relation to monoaminergic functions are described in this paper. Transcription factor AP-2β genotype has been studied in relation to personality, platelet monoamine oxidase (MAO) activity, CSF-levels of monoamine metabolites, binge-eating disorder, premenstrual dysphoric disorder, and schizophrenia. Furthermore, the involvement of AP-2 in the molecular mechanism of antidepressant drugs is discussed. Altogether, this paper discusses data supporting a notion that the transcription factor AP-2 family is involved in the regulation of the monoaminergic systems both pre- and postnatally, and, therefore, might be involved in the pathophysiology of neuropsychiatric disorders.
Similar content being viewed by others
References
J Angst R Sellaro KR Merikangas J Endicott (2001) ArticleTitleThe epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 104 110–116 Occurrence Handle10.1034/j.1600-0447.2001.00412.x Occurrence Handle11473504
SE Antonarkis JL Blouin AE Pulver P Wolyniec VK Lasseter G Nestadt L Kasch R Babb HH Kazazian B Dombroski M Kimberland J Ott D Housman M Karayiorgou CJ Maclean (1995) ArticleTitleSchizophrenia susceptibility and chromosome 6p24-22. Nat Genet 11 235–236 Occurrence Handle10.1038/ng1195-235 Occurrence Handle7581443
F Baskin YP Li LB Hersh RM Davis RN Rosenberg (1997) ArticleTitleAn AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience 76 821–827 Occurrence Handle10.1016/S0306-4522(96)00401-0 Occurrence Handle9135054
BJ Bassam G Caetano-Anolles PM Gresshoff (1991) ArticleTitleFast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196 80–83 Occurrence Handle10.1016/0003-2697(91)90120-I Occurrence Handle1716076
C Berggård M Damberg L Oreland (2003) ArticleTitleChronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain. Eur Neuropsychopharmacol 13 IssueID1 11–17 Occurrence Handle10.1016/S0924-977X(02)00075-5 Occurrence Handle12480117
Berggård C, Damberg M, Oreland L (2005) Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram. BMC Pharmacol 21;5(1): 1
P Blier Y Chaput C de Montigny (1988) ArticleTitleLong-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 337 246–254 Occurrence Handle10.1007/BF00168834 Occurrence Handle3260661
P Blier C de Montigny (1994) ArticleTitleCurrent advances and trends in the treatment of depression. Trends Pharmacol Sci 15 IssueID7 220–226 Occurrence Handle10.1016/0165-6147(94)90315-8 Occurrence Handle7940983
JM Bosher NF Totty JJ Hsuan T Williams HC Hurst (1996) ArticleTitleA family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13 1701–1707 Occurrence Handle8895516
CC Bradely RD Blakely (1997) ArticleTitleAlternative splicing of the human serotonin transporter gene. J Neurochem 69 1356–1367 Occurrence Handle9326263
DT Brewerton (1995) ArticleTitleToward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20 561–590 Occurrence Handle10.1016/0306-4530(95)00001-5 Occurrence Handle8584599
TD Brewerton DC Jimerson (1996) ArticleTitleStudies of serotonin function in anorexia nervosa. Psychiatry Res 62 IssueID1 31–42 Occurrence Handle10.1016/0165-1781(96)02987-3 Occurrence Handle8739113
T Butt SK Karathanasis (1995) ArticleTitleTranscription factors as drug targets: opportunities for therapeutic selectivity. Gene Expr 4 319–336 Occurrence Handle7549464
C Chazaud M Oulad-Abdelghani P Bouillet D Decimo P Chambon P Dolle (1996) ArticleTitleAP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 54 83–94 Occurrence Handle10.1016/0925-4773(95)00463-7 Occurrence Handle8808408
Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
DE Comings (1998) ArticleTitlePolymorphic inheritance and micro/minisatellites. Mol Psychiatry 3 21–31 Occurrence Handle10.1038/sj.mp.4000289 Occurrence Handle9491809
A Cravchik D Goldman (2000) ArticleTitleNeurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch Gen Psychiatry 57 1105–1114 Occurrence Handle10.1001/archpsyc.57.12.1105 Occurrence Handle11115324
M Damberg H Garpenstrand J Alfredsson J Ekblom K Forslund G Rylander L Oreland (2000a) ArticleTitleA polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits. Mol Psychiatry 5 220–224 Occurrence Handle10.1038/sj.mp.4000691
M Damberg H Garpenstrand C Berggard M Åsberg J Hallman L Oreland (2000b) ArticleTitleThe genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity. Neurosci Lett 291 204–206 Occurrence Handle10.1016/S0304-3940(00)01405-1
M Damberg J Ekblom L Oreland (2000c) ArticleTitleChronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci 68 669–678 Occurrence Handle10.1016/S0024-3205(00)00969-3
M Damberg M Eller M Tõnissaar L Oreland J Harro (2001a) ArticleTitleLevels of transcription factors AP-2α and AP-2β in the brainstem are correlated to monoamine levels in the rat forebrain. Neurosci Lett 313 102–104 Occurrence Handle10.1016/S0304-3940(01)02243-1
M Damberg H Garpenstrand J Hallman L Oreland (2001b) ArticleTitleGenetic mechanisms of behaviour-don’t forget about the transcription factors. Mol Psychiatry 6 503–510 Occurrence Handle10.1038/sj.mp.4000935
M Damberg C Berggard M Mattila-Evenden G Rylander K Forslund H Garpenstrand H Bergman JP Gustavsson EG Jonsson (2003a) ArticleTitleTranscription factor AP-2beta genotype associated with anxiety-related personality traits in women. A replication study. Neuropsychobiology 48 IssueID4 169–175 Occurrence Handle10.1159/000074633
M Damberg C Berggard L Oreland (2003b) ArticleTitlePhenelzine treatment increases transcription factor AP-2 levels in rat brain. BMC Pharmacol 3 10 Occurrence Handle10.1186/1471-2210-3-10
M Damberg C Berggard L Farde GC Sedvall EG Jonsson (2004) ArticleTitleTranscription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. J Neural Transm 111 537–545 Occurrence Handle10.1007/s00702-003-0097-4 Occurrence Handle15057523
M Damberg L Westberg C Berggård M Landen C Sundblad O Eriksson T Naessén A Ekman E Eriksson (2005) ArticleTitleInvestigation of transcription factor AP-2beta genotype in women with premenstrual dysphoric disorder. Neurosci Lett 377 IssueID1 49–52 Occurrence Handle10.1016/j.neulet.2004.11.068 Occurrence Handle15722186
AF Davies RJ Stephens MG Olavsen L Heather MJ Dixon A Magee F Flinter J Ragoussis (1995) ArticleTitleEvidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet 4 121–128 Occurrence Handle7711723
RA Depue PF Collins (1999) ArticleTitleNeurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22 491–569 Occurrence Handle10.1017/S0140525X99002046 Occurrence Handle11301519
YL Du BD Wilcox M Teitler JJ Jeffrey (1994) ArticleTitleIsolation and characterization of the rat 5-hydroxitryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 45 1125–1131 Occurrence Handle8022406
RS Duman GR Heninger EJ Nestler (1994) ArticleTitleMolecular psychiatry. Adaptations of receptorcoupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 182 IssueID12 692–700 Occurrence Handle7989913
RS Duman J Malberg J Thome (1999) ArticleTitleNeural plasticity to stress and antidepressant treatment. Biol Psychiatry 46 IssueID9 1181–1191 Occurrence Handle10.1016/S0006-3223(99)00177-8 Occurrence Handle10560024
JG Emery EH Ohlstein M Jaye (2001) ArticleTitleTherapeutic modulation of transcription factor activity. Trends Pharmacol Sci 22 233–240 Occurrence Handle10.1016/S0165-6147(00)01661-8 Occurrence Handle11339974
E Eriksson (1999) ArticleTitleSerotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 14 S27–S33
E Eriksson B Andersch HP Ho M Landen C Sundblad (2002) ArticleTitleDiagnosis and treatment of premenstrual dysphoria. J Clin Psychiatry 63 IssueID7 16–23
E Eriksson MA Hedberg B Andersch C Sundblad (1995) ArticleTitleThe serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of prementrual syndrome. Neuropsychopharmacology 12 167–176 Occurrence Handle10.1038/sj.npp.1380251 Occurrence Handle7779245
M Foot D Koszycki (2004) ArticleTitleGender differencies in anxiety-related traits in patients with panic disorder. Depression Anxiety 20 123–130 Occurrence Handle10.1002/da.20031
D Greco E Zellmer Z Zhang E Lewis (1995) ArticleTitleTranscription factor AP-2 regulates expression of the dopamine β-hydroxylase gene. J Neurochem 65 510–516 Occurrence Handle7616204
SL Hahn M Hahn UJ Kang TH Joh (1993) ArticleTitleStructure of the rat aromatic L-amino acid decarboxylase gene: evidence for an alternative promoter usage. J Neurochem 60 1058–1064 Occurrence Handle8436958
J Hartmann G Kunig P Riederer (1993) ArticleTitleInvolvement of transmitter systems in neuropsychiatric diseases. Acta Neurol Scand (Suppl) 146 18–21
DP Healy DA O’Rourke (1997) ArticleTitleRegulation of dopamine-1A (D1A) receptor gene transcription. Clin Exp Hypertens 19 1–13 Occurrence Handle9028631
A Heguy AA Stewart JD Haley DE Smith JG Foulkes (1995) ArticleTitleGene expression as a target for new drug discovery. Gene Expr 4 IssueID6 337–344 Occurrence Handle7549465
CJ Hudson LT Young PP Li JJ Warsh (1993) ArticleTitleCNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13 IssueID3 278–293 Occurrence Handle10.1002/syn.890130311 Occurrence Handle8497811
LH Hurley (1989) ArticleTitleDNA and associated targets for drug design. J Med Chem 32 IssueID9 2027–2033 Occurrence Handle10.1021/jm00129a001 Occurrence Handle2671370
M Imagawa R Chiu M Karin (1987) ArticleTitleTranscription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 251–260 Occurrence Handle10.1016/0092-8674(87)90152-8 Occurrence Handle2822255
KJ Irizarry B Merriman ME Bahamonde ML Wong J Licinio (2005) ArticleTitleThe evolution of signaling complexity suggests a mechanism for reducing the genomic search space in human association studies. Mol Psychiatry 10 IssueID1 14–26 Occurrence Handle10.1038/sj.mp.4001576 Occurrence Handle15618953
E Jönsson M Damberg K Forslund M Mattila-Evenden G Rylander M Åsberg L Oreland G Sedvall (2002) ArticleTitleNo association between a transcription factor activating protein 2beta (AP-2beta) gene variant and schizophrenia. Neurosci Lett 330 290 Occurrence Handle10.1016/S0304-3940(02)00818-2 Occurrence Handle12270648
Y Kawanishi S Harada H Tachikawa T Okubo H Shiraishi (2000) ArticleTitleNovel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia. J Hum Genet 45 24–30 Occurrence Handle10.1007/s100380050005 Occurrence Handle10697959
JM Kent JD Coplan JM Gorman (1998) ArticleTitleClinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 44 812–824 Occurrence Handle10.1016/S0006-3223(98)00210-8 Occurrence Handle9807637
CH Kim P Ardayfio KS Kim (2001) ArticleTitleAn E-box motif residing in the exon/intron 1 junction regulates both transcriptional activation and splicing of the human norepinephrine transporter gene. J Biol Chem 276 24797–24805 Occurrence Handle10.1074/jbc.M101279200 Occurrence Handle11333263
HS Kim SJ Hong MS LeDoux KS Kim (2001) ArticleTitleRegulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2. J Neurochem 76 280–294 Occurrence Handle10.1046/j.1471-4159.2001.00044.x Occurrence Handle11146001
E Kjelsås LB Augestad (2004) ArticleTitleGender, eating behavior, and personality characteristics in physically active students. Scand J Med Sci Sports 14 258–268 Occurrence Handle10.1111/j.1600-0838.2003.00343.x Occurrence Handle15265148
K Kobayashi Y Kurosawa K Fujita T Nagatsu (1989) ArticleTitleHuman dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucl Acids Res 17 IssueID3 1089–1102 Occurrence Handle2922261
GF Koob EJ Nestler (1997) ArticleTitleThe neurobiology of drug addiction. J Neuropsychiatr Clin Neurosci 9 482–497
A Laakso E Wallius J Kajander J Bergman O Eskola O Solin T Ilonen RKR Salokangas E Syvälathi J Hietala (2003) ArticleTitlePersonality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry 160 904–910 Occurrence Handle10.1176/appi.ajp.160.5.904 Occurrence Handle12727694
M Linnoila M Virkkunen T George D Higley (1993) ArticleTitleImpulse control disorders. Int Clin Psychopharmacol 8 IssueIDSuppl 1 53–56
KP Lesch (2001) ArticleTitleSerotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 62 57–76 Occurrence Handle10.1016/S0165-0327(00)00351-7 Occurrence Handle11172874
KP Lesch (2004) ArticleTitleGene-environment interactions and the genetics of depression. J Psychiatr Neurosci 29 IssueID3 174–184
KP Lesch A Heils (2000) ArticleTitleSerotonergic gene transcriptional control regions: targets for antidepressant drug development? Int J Neuropsychopharmacol 3 67–79 Occurrence Handle10.1017/S1461145700001747 Occurrence Handle11343581
KP Lesch U Merschdorf (2000) ArticleTitleImpulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 18 581–604 Occurrence Handle10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L Occurrence Handle11113963
I Lucki (1998) ArticleTitleThe spectrum of behaviors influenced by serotonin. Biol Psychiatry 44 151–162 Occurrence Handle10.1016/S0006-3223(98)00139-5 Occurrence Handle9693387
HK Manji R McNamara G Chen RH Lenox (1999) ArticleTitleSignalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. Aust NZ J Psychiatry 33 IssueIDSuppl S65–S83
M McDonough N Kennedy (2002) ArticleTitlePharmacological management of obsessive-compulsive disorder: a review for clinicians. Harv Rev Psychiatry 10 127–137 Occurrence Handle10.1080/10673220216215 Occurrence Handle12023928
M McMahon E Sabban (1992) ArticleTitleRegulation of expression of dopamine β-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J Neurochem 59 2040–2204 Occurrence Handle1359011
PJ Mitchell C Wang R Tjian (1987) ArticleTitlePositive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50 847–861 Occurrence Handle10.1016/0092-8674(87)90512-5 Occurrence Handle3040262
PJ Mitchell PM Timmons JM Herbert PW Rigby R Tjian (1991) ArticleTitleTranscription factor AP-2 is expressed in neural crest lineages during mouse embryogenesis. Genes Dev 5 105–119 Occurrence Handle1989904
R Mongeau P Blier de Montigny (1997) ArticleTitleThe serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23 IssueID3 145–195 Occurrence Handle10.1016/S0165-0173(96)00017-3 Occurrence Handle9164669
M Morishita T Kishino K Furukawa A Yonekura Y Miyazaki T Kanematsu S Yamashita T Tsukazaki (2001) ArticleTitleA 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5. Biochem Biophys Res Commun 288 347–355 Occurrence Handle10.1006/bbrc.2001.5778 Occurrence Handle11606049
M Moser A Imhof A Pscherer R Bauer W Amselgruber F Sinowatz F Hofstadter R Schule R Buettner (1995) ArticleTitleCloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 121 2779–2788 Occurrence Handle7555706
M Moser J Rüschoff R Buettner (1997a) ArticleTitleComparative analysis of AP-2α and AP-2β gene expression during murine embryogenesis. Dev Dyn 208 115–124 Occurrence Handle10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5
M Moser A Pscherer C Roth J Becker G Mücher K Zerres C Dixkens J Weis L Guay-Woodford R Buettner R Fässler (1997b) ArticleTitleEnhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev 11 1938–1948
MJ Nibuya EJ Nestler R Duman (1996) ArticleTitleChronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 IssueID7 2365–2372 Occurrence Handle8601816
L Oreland EG Shaskan (1983) ArticleTitleMonoamine oxidase activity as a biological marker. Trends Pharmacol Sci 4 339–341 Occurrence Handle10.1016/0165-6147(83)90432-7
M Oulad-Abdelghani P Bouillet C Chazaud P Dolle P Chambon (1996) ArticleTitleAP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp Cell Res 225 338–347 Occurrence Handle10.1006/excr.1996.0184 Occurrence Handle8660922
T Palomo RJ Beninger RM Kostrzewa T Archer (2004) ArticleTitleGene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes. Neurotox Res 6 IssueID3 159–173 Occurrence Handle15325956
AG Papavassiliou (1998) ArticleTitleTranscription-factor-modulating agents: precision and selectivity in drug design. Mol Med Today 4 358–366 Occurrence Handle10.1016/S1357-4310(98)01303-3 Occurrence Handle9755455
KR Pennypacker (1995) ArticleTitlePharmacological regulation of transcription factor binding. Pharmacology 51 1–12 Occurrence Handle7568339
A Petronis II Gottesman TJ Crow LE DeLisi AJ Klar F Macciardi MG McInnis FJ McMahon AD Paterson D Skuse GR Sutherland (2000) ArticleTitlePsychiatric epigenetics: a new focus for the new century. Mol Psychiatry 5 IssueID4 342–346 Occurrence Handle10.1038/sj.mp.4000750 Occurrence Handle10889541
M Popoli N Brunello J Perez G Racagni (2000) ArticleTitleSecond messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem 74 IssueID1 21–33 Occurrence Handle10.1046/j.1471-4159.2000.0740021.x Occurrence Handle10617102
C Quirin-Stricker C Mauvais M Schmitt (1997) ArticleTitleTranscriptional activation of human choline acetyltransferase by AP2- and NGF-induced factors. Brain Res Mol Brain Res 49 165–174 Occurrence Handle10.1016/S0169-328X(97)00141-1 Occurrence Handle9387876
WJ Roesler GR Vandenbark RW Hanson (1988) ArticleTitleCyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 263 9063–9066
A Sawa SH Snyder (2002) ArticleTitleSchizophrenia: diverse approaches to a complex disease. Science 296 IssueID5568 692–695 Occurrence Handle10.1126/science.1070532 Occurrence Handle11976442
SG Schwab M Albus J Hallmeyer S Hönig M Borrman D Lichtermann RP Ebstein M Ackenheil B Lerer N Risch W Maier DB Wildenauer (1995) ArticleTitleEvaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 11 325–327 Occurrence Handle10.1038/ng1195-325 Occurrence Handle7581458
M Shimada Y Konishi N Ohkawa C Ohtaka-Maruyama F Hanaoka Y Makino T Tamura (1999) ArticleTitleDistribution of AP-2 subtypes in the adult mouse brain. Neurosci Res 33 275–280 Occurrence Handle10.1016/S0168-0102(99)00017-6 Occurrence Handle10401980
DJ Stein HG Westenberg MR Liebowitz (2002) ArticleTitleSocial anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry 63 IssueIDSuppl 6 12–19
F Sulser (1989) ArticleTitleNew perspectives on the molecular pharmacology of affective disorders. Eur Arch Psychiatry Neurol Sci 238 IssueID5–6 231–239 Occurrence Handle10.1007/BF00449803 Occurrence Handle2548868
KH Surinya TC Cox BK May (1998) ArticleTitleIdentification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem 273 16798–16809 Occurrence Handle10.1074/jbc.273.27.16798 Occurrence Handle9642238
S Takeuchi M Waragi C Roth I Kanazawa R Buettner MM Mouridan H Kazawa (1999) Brain Res Mol Brain Res 74 208 Occurrence Handle10.1016/S0169-328X(99)00298-3 Occurrence Handle10640692
J Thome N Sakai K Shin C Steffen YJ Zhang S Impey D Storm RS Duman (2000) ArticleTitlecAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20 IssueID11 4030–4036 Occurrence Handle10818138
G Van Haasteren S Li S Ryser W Schlegel (2000) ArticleTitleEssential contribution of intron sequences to Ca(2+)-dependent activation of c-fos transcription in pituitary cells. Neuroendocrinology 72 368–378 Occurrence Handle10.1159/000054606 Occurrence Handle11146420
HV Wang K Vaupel R Buettner AK Bosserhoff M Moser (2004) ArticleTitleIdentification and embryonic expression of a new AP-2 transcription factor, AP-2epsilon. Dev Dyn 231 128–135 Occurrence Handle10.1002/dvdy.20119 Occurrence Handle15305293
S Wang CE Sun CA Walczak JS Ziegle BR Kipps LR Goldin SR Diehl (1995) ArticleTitleEvidence for a susceptibility locus for schizophrenia on chreomosaome 6pter-p22. Nat Genet 10 40–46 Occurrence Handle10.1038/nm969
T Williams A Admon B Luscher R Tjian (1988) ArticleTitleCloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2 1557–1569 Occurrence Handle3063603
T Williams R Tjian (1991a) ArticleTitleAnalysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 5 670–682
T Williams R Tjian (1991b) ArticleTitleCharacterization of a dimerization motif in AP-2 and its function in heterologous DNA binding proteins. Science 251 1067–1071
F Zhao M Satoda JD Licht Y Hayashizaki BD Gelb (2001) ArticleTitleCloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 276 40755–40760 Occurrence Handle10.1074/jbc.M106284200 Occurrence Handle11522791
M Zuckerman (1993) ArticleTitleP-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuropsychobiology 28 30–36 Occurrence Handle8255407
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damberg, M. Transcription factor AP-2 and monoaminergic functions in the central nervous system. J Neural Transm 112, 1281–1296 (2005). https://doi.org/10.1007/s00702-005-0325-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-005-0325-1